Betaville Intelligence

RARE ALERT: GlaxoSmithKline said to ... - Part 5

The European-based investor group seeking to persuade the board of Aurinia Pharmaceuticals to carry out a strategic review has appointed a US lawyer to manage an action group for other investors looking to back its activist campaign.

The move comes as the investment consortium, led by the Switzerland-based MKT Tactical Fund, recently wrote a second letter to the chairman of Aurinia, George Milne Junior...


Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Tuesday, 22 March 2022, 4:24 pm

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation